Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Sleep Medicine

What Do Polysomnography and FDG-PET Show in Suspected FFI?

At a Glance

In suspected fatal familial insomnia, polysomnography may show severely disrupted, shortened sleep, while FDG-PET may show reduced glucose use in the thalamus. Both tests are supportive only, and normal results do not rule out FFI.

When doctors suspect fatal familial insomnia (FFI)—a rare inherited prion disease (a condition caused by abnormally folded proteins in the brain)—they must piece together a complex puzzle [1]. Diagnosis depends heavily on your clinical symptoms, family history, and genetic testing [2][3].

To gather more clues, your doctor may recommend two supportive tests: a video sleep study (called video-polysomnography) and a specialized brain scan called an FDG-PET scan [4][5]. These tests are optional or supportive investigations used in selected cases. Neither test can diagnose FFI on its own, nor do they measure exactly how your illness will progress [6][3]. Instead, they help rule out other conditions and identify patterns of sleep disruption and brain energy use that may suggest FFI [7][8].

How These Tests Fit Together

Confirming an FFI diagnosis involves multiple steps. Your doctor will evaluate your symptom history and neurologic exam, and they may use MRI, EEG, or spinal fluid tests to rule out other causes of severe insomnia, such as autoimmune conditions or other prion diseases like sporadic Creutzfeldt-Jakob disease [1][9].

Genetic testing is a central piece of this puzzle [3]. FFI is typically associated with a specific mutation in the PRNP gene called D178N, specifically when it occurs alongside a “methionine” (M) variation at codon 129 on the same gene [2]. Finding the D178N mutation with a different variation at codon 129 can cause a different disease entirely, and finding the mutation does not guarantee your current symptoms are FFI [2]. Because predictive genetic testing for a rapidly progressive illness has profound implications for you and your family, it should always involve pre- and post-test counseling with a genetic counselor [10][11].

The Video Sleep Study (Polysomnography)

A video-polysomnography evaluates abnormal sleep physiology. It is an overnight test conducted in a specialized sleep center [12].

What You Will Experience

During the setup, a technician will place small, painless sensors on your scalp, face, chest, and limbs [13]. These sensors record brain waves (EEG), eye movements, muscle activity, and heart rhythm [14][13]. You will wear elastic belts around your chest and abdomen to measure breathing effort, a finger clip to track oxygen, and a sensor near your nose to monitor airflow [13]. A video camera records your movements to help doctors correlate physical actions with brain wave activity [15][4]. The setup takes about an hour, and while wearing the wires can feel cumbersome, the procedure itself is non-invasive and safe [13].

What the Sleep Study May Show

In people with FFI, normal sleep architecture (the natural progression through sleep stages) becomes severely disrupted, though brief periods of abnormal sleep usually persist [7][15]. Findings that are characteristic or supportive of suspected FFI include:

  • Loss of specific sleep stages: A marked reduction in sleep spindles (short bursts of brain activity normally seen in light sleep) and slow-wave sleep (the deepest, most restorative sleep stage) [15].
  • Rapid shifts: The brain may rapidly cycle between periods of wakefulness and short bursts of non-restorative sleep [7].
  • Reduced overall sleep: A marked decrease in total sleep time [7].

Other findings may occur but are nonspecific and can happen in many other conditions:

  • Abnormal REM sleep: The dream phase (REM sleep) may be reduced [7]. Sometimes, the normal muscle paralysis of REM sleep is lost (REM sleep without atonia), leading to dream enactment or twitching [15][16].
  • Breathing issues: The study may capture sleep apnea or abnormal breathing sounds (stridor), which can prompt separate respiratory evaluations but do not prove you have FFI [7][17].

Importantly, a sleep study can be inconclusive. Unfamiliar settings, medications, and the stage of your disease can all affect the results, meaning a normal or unclear study does not rule out FFI. Do not stop prescribed medications before the study unless directed by your sleep team.

The FDG-PET Brain Scan

An FDG-PET scan measures how different areas of your brain use glucose (sugar) for energy [8]. It does not directly show structural brain damage, but rather highlights areas that are underperforming chemically (hypometabolism) [8].

What You Will Experience

You will receive a small injection of a radiotracer, which carries a low but non-zero amount of radiation exposure [18]. You will rest quietly for 30 to 60 minutes while your brain absorbs the tracer, then lie still inside a scanner for about 30 minutes [18].

Because the tracer relies on sugar, you must follow your specific imaging center’s instructions regarding fasting duration, medication use, and managing diabetes or blood sugar control [18]. You must also inform them if you are pregnant, breastfeeding, or scheduled for a combined CT scan.

What the FDG-PET Scan May Show

In FFI, an FDG-PET scan may show:

  • Thalamic hypometabolism: Reduced energy use in the thalamus, the brain’s main relay center that helps regulate sleep and wakefulness [8][19].
  • Variable spread: Reduced energy use may sometimes be seen in other areas, such as the basal ganglia (deep brain structures involved in movement) and the outer layer of the brain (the cerebral cortex) [6][8]. This spread varies widely between patients.

Crucially, a “normal” FDG-PET scan does not rule out FFI. There have been genetically confirmed cases where the scan showed no significant abnormalities or lacked the typical thalamic pattern [1][20].

Seeking Specialized Care

Interpreting the subtle changes seen in these tests requires significant expertise [3]. It is important to have your tests coordinated by a tertiary care center (a major hospital with advanced specialists) or a doctor experienced in prion diseases, sleep medicine, or neurogenetics (the study of genetic brain disorders) [3][4].

Because FFI and similar conditions can progress quickly, contact your medical team urgently if you or a loved one experience sudden confusion, frequent falls, inability to eat or drink, swallowing or breathing problems, or unsafe nighttime behaviors. Ensuring your symptom relief and safety is a priority even while diagnostic tests are still being arranged.

Common questions in this guide

What might a video-polysomnography show in fatal familial insomnia?
It may show severely disrupted sleep architecture, with fewer sleep spindles and markedly reduced slow-wave sleep. Sleep can shift rapidly between wakefulness and brief, non-restorative periods, with less total sleep. REM changes or abnormal breathing can occur but are not specific to FFI.
What can an FDG-PET scan reveal in FFI?
It may show hypometabolism, or reduced glucose use, in the thalamus, which helps regulate sleep and wakefulness. Reduced activity may also involve the basal ganglia or cerebral cortex, but patterns vary. A normal scan does not rule out FFI.
Can polysomnography or FDG-PET confirm fatal familial insomnia?
No. Both are supportive tests, and neither can diagnose FFI by itself; doctors interpret them alongside symptoms, family history, neurologic examination, and genetic testing. Other tests may be used to exclude autoimmune disease or other prion diseases.
What does a normal or inconclusive result mean?
A normal or unclear sleep study or FDG-PET scan does not exclude fatal familial insomnia. Results can be affected by medications, the testing environment, disease stage, and variation in brain-scan findings. Your medical team may recommend specialist review and additional testing based on the complete clinical picture.
How should I prepare for an FDG-PET scan?
Follow the imaging center's instructions about fasting, medications, and blood-sugar management, especially if you have diabetes. Tell the team if you are pregnant, breastfeeding, or scheduled for a combined CT scan. Do not change prescribed medicines unless the imaging or medical team tells you to.
Should I get genetic counseling before PRNP testing?
Yes, genetic counseling before and after testing can help you understand what a PRNP result may mean for your diagnosis and family. The D178N mutation is typically linked to FFI when it occurs with methionine at codon 129, but finding the mutation alone does not prove that current symptoms are FFI. A genetics professional can discuss emotional, medical, and family implications.

Get notified when new evidence is published on Fatal familial insomnia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (20)
  1. 1

    Genetic prion disease: D178N with 129MV disease modifying polymorphism-a clinical phenotype.

    Tan TH, Stark RJ, Waterston JA, et al.

    BMJ neurology open 2020; (2(2)):e000074 doi:10.1136/bmjno-2020-000074.

    PMID: 33681799
  2. 2

    Fatal familial insomnia and sporadic fatal insomnia.

    Cracco L, Appleby BS, Gambetti P

    Handbook of clinical neurology 2018; (153()):271-299 doi:10.1016/B978-0-444-63945-5.00015-5.

    PMID: 29887141
  3. 3

    Analysis of a large case series of fatal familial insomnia to determine tests with the highest diagnostic value.

    Kortazar-Zubizarreta I, Eraña H, Pereda A, et al.

    Journal of neuropathology and experimental neurology 2023; (82(2)):169-179 doi:10.1093/jnen/nlac113.

    PMID: 36458954
  4. 4

    Stridor during sleep: description of 81 consecutive cases diagnosed in a tertiary sleep disorders center.

    Silva C, Iranzo A, Maya G, et al.

    Sleep 2021; (44(3)) doi:10.1093/sleep/zsaa191.

    PMID: 32954431
  5. 5

    Sleep architecture and sleep-disordered breathing in fatal insomnia.

    Pérez-Carbonell L, Muñoz-Lopetegi A, Sánchez-Valle R, et al.

    Sleep medicine 2022; (100()):311-346 doi:10.1016/j.sleep.2022.08.027.

    PMID: 36182725
  6. 6

    Follow-up multimodal changes on PET/MRI in fatal familial insomnia patient: a case report.

    Chen Z, Wu L, Yan S, Lu J

    BMC neurology 2025; (25(1)):301 doi:10.1186/s12883-025-04315-0.

    PMID: 40722143
  7. 7

    Clinical Features and Sleep Analysis of Chinese Patients with Fatal Familial Insomnia.

    Wu L, Lu H, Wang X, et al.

    Scientific reports 2017; (7(1)):3625 doi:10.1038/s41598-017-03817-3.

    PMID: 28620158
  8. 8

    Specific structuro-metabolic pattern of thalamic subnuclei in fatal familial insomnia: A PET/MRI imaging study.

    Xie K, Chen Y, Chu M, et al.

    NeuroImage. Clinical 2022; (34()):103026 doi:10.1016/j.nicl.2022.103026.

    PMID: 35504222
  9. 9

    Clinical manifestations and polysomnography-based analysis in nine cases of probable sporadic Creutzfeldt-Jakob disease.

    Dai Y, Shao J, Lang Y, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2021; (42(10)):4209-4219 doi:10.1007/s10072-021-05102-8.

    PMID: 33559029
  10. 10

    Genetic counseling for prion disease: Updates and best practices.

    Goldman JS, Vallabh SM

    Genetics in medicine : official journal of the American College of Medical Genetics 2022; (24(10)):1993-2003 doi:10.1016/j.gim.2022.06.003.

    PMID: 35819418
  11. 11

    Preventive pharmacological treatment in subjects at risk for fatal familial insomnia: science and public engagement.

    Forloni G, Roiter I, Artuso V, et al.

    Prion 2022; (16(1)):66-77 doi:10.1080/19336896.2022.2083435.

    PMID: 35737759
  12. 12

    Validation of Contact-Free Sleep Monitoring Device with Comparison to Polysomnography.

    Tal A, Shinar Z, Shaki D, et al.

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2017; (13(3)):517-522 doi:10.5664/jcsm.6514.

    PMID: 27998378
  13. 13

    Utility of portable monitoring in the diagnosis of obstructive sleep apnea.

    Krishnaswamy U, Aneja A, Kumar RM, Kumar TP

    Journal of postgraduate medicine 2015; (61(4)):223-9 doi:10.4103/0022-3859.166509.

    PMID: 26440391
  14. 14

    Polysomnography.

    Rundo JV, Downey R

    Handbook of clinical neurology 2019; (160()):381-392 doi:10.1016/B978-0-444-64032-1.00025-4.

    PMID: 31277862
  15. 15

    Fatal familial insomnia presenting with agrypnia excitata and very low atonia index level: A case report and literature review.

    Yang TW, Park B, Kim KT, et al.

    Medicine 2018; (97(18)):e0646 doi:10.1097/MD.0000000000010646.

    PMID: 29718878
  16. 16

    Clinical Manifestations.

    Teixeira MS, Gomes AM, Epifanio HB, et al.

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2025; (21 Suppl 3()):e102926 doi:10.1002/alz70857_102926.

    PMID: 41447306
  17. 17

    Agrypnia excitata and obstructive apnea in a patient with fatal familial insomnia from China: A case report.

    Sun C, Xia W, Liu Y, et al.

    Medicine 2017; (96(49)):e8951 doi:10.1097/MD.0000000000008951.

    PMID: 29245265
  18. 18

    EFFECTIVE RADIATION DOSE OF 18F-FDG PET/CT: HOW MUCH DOES DIAGNOSTIC CT CONTRIBUTE?

    Li Y, Jiang L, Wang H, et al.

    Radiation protection dosimetry 2019; (187(2)):183-190 doi:10.1093/rpd/ncz153.

    PMID: 31147708
  19. 19

    Metabolic patterns in prion diseases: an FDG PET voxel-based analysis.

    Prieto E, Domínguez-Prado I, Riverol M, et al.

    European journal of nuclear medicine and molecular imaging 2015; (42(10)):1522-9 doi:10.1007/s00259-015-3090-x.

    PMID: 26041084
  20. 20

    Fatal familial insomnia: A new case description with response to thoracic sympathetic nerve thermocoagulation and stellate ganglion block.

    Chen Y, Li Y, Zhou Y, et al.

    Sleep medicine 2025; (127()):24-27 doi:10.1016/j.sleep.2024.12.034.

    PMID: 39765140

This page explains what video-polysomnography and FDG-PET may show when fatal familial insomnia is suspected; it is for informational purposes only and does not constitute medical advice. These tests cannot diagnose FFI on their own, so discuss results and next steps with your medical team.